Morgan Stanley downgraded bluebird bio Inc. (Nasdaq: BLUE) from an Equal Weight rating to an Underweight rating sending the stock price plummeting $11.90 to close at $125.45.
bluebird bio downgraded
October 02, 2017 at 19:59 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.